Page last updated: 2024-08-21

pyrazines and bms 665053

pyrazines has been researched along with bms 665053 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fotsch, C; St Jean, DJ1
Ahuja, VT; Bronson, JJ; Hartz, RA; Huang, S; Leet, JE; Macor, JE; Shu, YZ; Vrudhula, VM; Wong, H; Zhuo, X1
Ahuja, VT; Bronson, JJ; Grace, JE; Hartz, RA; Lodge, NJ; Macor, JE; Vrudhula, VM1

Reviews

1 review(s) available for pyrazines and bms 665053

ArticleYear
Mitigating heterocycle metabolism in drug discovery.
    Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13

    Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats

2012

Other Studies

2 other study(ies) available for pyrazines and bms 665053

ArticleYear
Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:1

    Topics: Animals; Bile; Biotransformation; Glucuronic Acid; Glutathione; Humans; Liver; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microsomes, Liver; Models, Chemical; Molecular Structure; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Spectrophotometry, Ultraviolet

2010
Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF
    Bioorganic & medicinal chemistry letters, 2017, 03-15, Volume: 27, Issue:6

    Topics: Animals; Biological Availability; Prodrugs; Pyrazines; Rats; Receptors, Corticotropin-Releasing Hormone

2017